An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.
about
Lung cancer: epidemiology, etiology, and preventionA report of lung adenocarcinoma with HIV carrier and the literature reviewThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careEpidemic of lung cancer in patients with HIV infectionMechanisms Underlying HIV Associated Non-infectious Lung Disease.9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1HIV infection is associated with an increased risk for lung cancer, independent of smoking.Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.HIV infection in the etiology of lung cancer: confounding, causality, and consequencesLung cancer in HIV Infection.Lung cancer in HIV infected patients: facts, questions and challenges.HIV-Associated Lung Cancer.Non-infectious pulmonary disorders in HIV.Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation
P2860
Q24630167-184580F4-F84C-4A8F-8E88-21BD6756CBDFQ26820860-75D6434F-E3B8-403F-9A5F-205AE69100D0Q26991549-6CEDD649-CBFD-4854-A965-11AF9889AC2DQ27000028-F2171D9A-B0D0-4A9D-820D-3E433881B256Q30234727-01017482-1BC7-4E1D-9BA1-7963EFD0BCAAQ30438975-F9A141A5-3910-45B3-8F5A-DA1F8893DF14Q33787051-C19D234D-167E-4D3E-9DC2-6BBF516690F7Q33834602-29E9854D-23E5-4EF5-89BA-720B519924C5Q34158436-0BD578EC-DBA6-42BE-8ABB-24C182682A21Q35095062-7DB8EA41-A5FD-436B-B879-0EBB671ABB48Q35667193-8BADF119-1504-4366-92AD-83AFE7859E11Q36237964-BF20E43F-E523-4CFE-8270-24DB0AE6CEE5Q38929261-4C66F15C-034F-4D0F-95A5-EDA778C33235Q39106214-77A0AF7F-D5A6-4FDA-8EC4-ED564C567620Q40001150-89265CD9-7C35-480D-B002-70DC7AD07218
P2860
An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
An RGD containing peptide from ...... lar carcinoma cell line, A549.
@en
type
label
An RGD containing peptide from ...... lar carcinoma cell line, A549.
@en
prefLabel
An RGD containing peptide from ...... lar carcinoma cell line, A549.
@en
P2093
P2860
P1476
An RGD containing peptide from ...... lar carcinoma cell line, A549.
@en
P2093
J S Lwebuga-Mukasa
S A Schwartz
P2860
P304
P356
10.3109/08820139709022692
P577
1997-04-01T00:00:00Z